METHODS AND COMPOSITIONS FOR TREATING MOTOR NEURON DISEASES Application US-20220160745-A1 United States of America 26 May 2022
PHARMACEUTICAL COMPOSITION CONTAINING EDARAVONE AS AN ACTIVE AGENT Application WO-2021229466-A1 World Intellectual Property Organisation (WIPO) 18 Nov 2021